Literature DB >> 2143170

Patterns of membrane TcR alpha beta and TcR gamma delta chain expression by normal blood CD4+CD8-, CD4-CD8+, CD4-CD8dim+ and CD4-CD8- lymphocytes.

C S Scott1, S J Richards, B E Roberts.   

Abstract

Enriched CD4+CD8-/CD4-CD8-, CD4-CD8+/CD4-CD8- and CD4-CD8- cell suspensions were prepared from normal peripheral blood by selective immunomagnetic depletion of monoclonal antibody-defined lymphocyte populations. Subsequent examination of these modified cell fractions by two-colour flow cytometry provided a means of determining the expression of membrane T-cell receptor (TcR)alpha beta and TcR gamma delta chains by both major (CD4+ and CD8+) and minor (CD3+CD4-CD8dim+ and CD3+CD4-CD8-) lymphocyte subpopulations. Normal CD4+CD8- lymphocytes were almost invariably (greater than 99%) TcR alpha beta+, whereas lymphocytes expressing membrane CD8, which could be further subdivided according to differences in fluorescent staining intensity into CD3+CD4-CD8+, CD3+CD4-CD8dim+ and CD3-CD4-CD8dim+ components, were characterized by distinct differences in patterns of TcR chain expression. In contrast to CD3+CD4-CD8+ cells, which were predominantly (99%) TcR alpha beta+, CD3+CD4-CD8dim+ lymphocytes showed a significant proportion (33%) of TcR gamma delta+ cells (natural killer-associated CD3-CD4-CD8dim+ cells were uniformly TcR-). The highest proportion (62%) of TcR gamma delta+ cells was associated with the CD3+CD4-CD8- fraction, but these studies also revealed that a significant minority of this population was TcR alpha beta+. Despite some evidence for normal inter-individual variation, further analysis of membrane CD8 fluorescent intensities confirmed clear differential relationships for TcR alpha beta and TcR gamma delta chain expression.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2143170      PMCID: PMC1384165     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  10 in total

1.  Characteristics of a monoclonal antibody (WT-31) that recognizes a common epitope on the human T cell receptor for antigen.

Authors:  H Spits; J Borst; W Tax; P J Capel; C Terhorst; J E de Vries
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

2.  Immunology. Antigens for gamma/delta T cells.

Authors:  D H Raulet
Journal:  Nature       Date:  1989-06-01       Impact factor: 49.962

3.  Functional reactivity of WT31 monoclonal antibody with T cell receptor-gamma expressing CD3+4-8- T cells.

Authors:  R J van de Griend; J Borst; W J Tax; R L Bolhuis
Journal:  J Immunol       Date:  1988-02-15       Impact factor: 5.422

4.  A functional T3 molecule associated with a novel heterodimer on the surface of immature human thymocytes.

Authors:  I Bank; R A DePinho; M B Brenner; J Cassimeris; F W Alt; L Chess
Journal:  Nature       Date:  1986 Jul 10-16       Impact factor: 49.962

5.  Preparation of chromic chloride solutions for indirect rosetting: a rapid method.

Authors:  I D MacKarill; C S Scott; A N Stark; H J Limbert; P S Master; R A Jones; A Earnshaw
Journal:  Med Lab Sci       Date:  1987-10

6.  Identification of a putative second T-cell receptor.

Authors:  M B Brenner; J McLean; D P Dialynas; J L Strominger; J A Smith; F L Owen; J G Seidman; S Ip; F Rosen; M S Krangel
Journal:  Nature       Date:  1986 Jul 10-16       Impact factor: 49.962

7.  Recognition of cluster of differentiation 1 antigens by human CD4-CD8-cytolytic T lymphocytes.

Authors:  S Porcelli; M B Brenner; J L Greenstein; S P Balk; C Terhorst; P A Bleicher
Journal:  Nature       Date:  1989-10-05       Impact factor: 49.962

8.  Presence of Ti (WT31) negative T lymphocytes in normal blood and thymus.

Authors:  L L Lanier; A Weiss
Journal:  Nature       Date:  1986 Nov 20-26       Impact factor: 49.962

9.  T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis.

Authors:  S Shivakumar; G C Tsokos; S K Datta
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

10.  The T cell antigen receptor complex expressed on normal peripheral blood CD4-, CD8- T lymphocytes. A CD3-associated disulfide-linked gamma chain heterodimer.

Authors:  L L Lanier; N A Federspiel; J J Ruitenberg; J H Phillips; J P Allison; D Littman; A Weiss
Journal:  J Exp Med       Date:  1987-04-01       Impact factor: 14.307

  10 in total
  7 in total

1.  Gamma delta T lymphocytosis associated with common variable immunodeficiency.

Authors:  R K Katial; M M Lieberman; S L Muehlbauer; J A Lust; D L Hamilos
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

2.  Antigen recognition and activation of ovine gamma delta T cells.

Authors:  C W Evans; B T Lund; I McConnell; R Bujdoso
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

3.  GATA3 Abundance Is a Critical Determinant of T Cell Receptor β Allelic Exclusion.

Authors:  Chia-Jui Ku; JoAnn M Sekiguchi; Bharat Panwar; Yuanfang Guan; Satoru Takahashi; Keigyou Yoh; Ivan Maillard; Tomonori Hosoya; James Douglas Engel
Journal:  Mol Cell Biol       Date:  2017-05-31       Impact factor: 4.272

4.  Definition of unique traits of human CD4-CD8- alpha beta T cells.

Authors:  J G Murison; S Quaratino; M Kahan; A Verhoef; M Londei
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

5.  Deciphering the Contribution of γδ T Cells to Outcomes in Transplantation.

Authors:  Oliver McCallion; Joanna Hester; Fadi Issa
Journal:  Transplantation       Date:  2018-12       Impact factor: 4.939

6.  Variant CD45R expression with autosomal dominant inheritance affects both helper/inducer (CD4+) and suppressor/cytotoxic (CD8+) T cell populations.

Authors:  C S Scott; S J Richards; J C Cole; H C Gooi
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

7.  Distinct Features of Canine Non-conventional CD4-CD8α- Double-Negative TCRαβ+ vs. TCRγδ+ T Cells.

Authors:  Friederike V Rabiger; Kathrin Rothe; Heiner von Buttlar; Doris Bismarck; Mathias Büttner; Peter F Moore; Maria Eschke; Gottfried Alber
Journal:  Front Immunol       Date:  2019-11-22       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.